LKIM
GILD icon

Lawson Kroeker Investment Management’s Gilead Sciences GILD Stock Holding History

Lawson Kroeker Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,730
Closed -$890K – 82
2023
Q1 		$890K Sell
10,730
-46,666
-81% -$3.87M 0.2% 66
2022
Q4 		$4.93M Sell
57,396
-3,505
-6% -$278K 1.66% 25
2022
Q3 		$3.76M Buy
60,901
+15
+0% +$946 1.32% 29
2022
Q2 		$3.76M Sell
60,886
-1,400
-2% -$86.7K 1.27% 32
2022
Q1 		$3.7M Buy
62,286
+1,233
+2% +$78.8K 1.17% 30
2021
Q4 		$4.43M Sell
61,053
-145
-0.2% -$9.99K 1.38% 29
2021
Q3 		$4.28M Sell
61,198
-1,050
-2% -$73.8K 1.42% 29
2021
Q2 		$4.29M Buy
62,248
+493
+0.8% +$32.9K 1.36% 26
2021
Q1 		$3.99M Buy
61,755
+2,077
+3% +$134K 1.36% 28
2020
Q4 		$3.48M Sell
59,678
-25,755
-30% -$1.55M 1.3% 28
2020
Q3 		$5.4M Sell
85,433
-50
-0.1% -$3.47K 2.41% 15
2020
Q2 		$6.58M Sell
85,483
-240
-0.3% -$18.4K 3.1% 12
2020
Q1 		$6.41M Buy
85,723
+23,340
+37% +$1.61M 3.57% 10
2019
Q4 		$4.05M Sell
62,383
-2,465
-4% -$161K 1.5% 26
2019
Q3 		$4.11M Sell
64,848
-19,040
-23% -$1.24M 1.56% 26
2019
Q2 		$5.67M Sell
83,888
-265
-0.3% -$17.4K 1.9% 22
2019
Q1 		$5.47M Sell
84,153
-870
-1% -$57.8K 1.95% 20
2018
Q4 		$5.32M Sell
85,023
-13,065
-13% -$913K 2.09% 19
2018
Q3 		$7.57M Buy
98,088
+925
+1% +$69.9K 2.46% 16
2018
Q2 		$6.88M Sell
97,163
-14,984
-13% -$1.06M 2.45% 16
2018
Q1 		$8.46M Buy
112,147
+50
+0% +$3.98K 2.77% 15
2017
Q4 		$8.03M Sell
112,097
-8,295
-7% -$630K 2.58% 16
2017
Q3 		$9.75M Sell
120,392
-530
-0.4% -$40.5K 3.07% 11
2017
Q2 		$8.56M Buy
120,922
+34
+0% +$2.26K 2.87% 14
2017
Q1 		$8.21M Buy
120,888
+23,395
+24% +$1.65M 2.78% 14
2016
Q4 		$6.98M Sell
97,493
-31,836
-25% -$2.37M 2.4% 18
2016
Q3 		$10.2M Buy
129,329
+24,975
+24% +$2.03M 3.3% 8
2016
Q2 		$8.71M Buy
104,354
+29,944
+40% +$2.66M 2.89% 12
2016
Q1 		$6.83M Buy
+74,410
New +$6.71M 2.35% 18

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lawson Kroeker Investment Management's GILD Position: Q2 2023 in Review

Lawson Kroeker Investment Management sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 10,730 shares — an estimated $890K sold.

Lawson Kroeker Investment Management first reported a position in GILD in Q1 2016 and held it in 29 quarters. The position peaked at $10.2M in Q3 2016. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Lawson Kroeker Investment Management reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • Lawson Kroeker Investment Management sold 10,730 Gilead Sciences shares in Q2 2023, an estimated $890K.
  • Lawson Kroeker Investment Management first reported a position in Gilead Sciences in Q1 2016 and held it in 29 quarters.
  • Lawson Kroeker Investment Management's Gilead Sciences position peaked at $10.2M in Q3 2016.
  • 1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Lawson Kroeker Investment Management's 13F filing for Q2 2023, filed 24 Jul 2023.